Abstract
Venous or arterial thrombosis after cardiac catheterization is one of the Most frequent adverse events. Anticoagulation with heparin reduces this risk of thromboembolic complications during cardiac catheterization in both children and adults. Different dosages and Modalities of heparin administration, from heparin bolus therapy to low-dose flush heparin, have been recommended for the pediatric cardiac catheterization laboratories.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Roschitz, B. et al. (2003). UFH Bolus Administration in Comparison to subcutaneous Low Molecular Weight Heparin in pediatric cardiac Catheterization. In: Scharrer, I., Schramm, W. (eds) 32nd Hemophilia Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18150-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-18150-4_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-43884-7
Online ISBN: 978-3-642-18150-4
eBook Packages: Springer Book Archive